Food Allergy Market to Witness Remarkable Growth, Key Insights, and Global Outlook Revealed in New 2031 Forecast Report
February 06, 2024 10:06 ET
|
Research and Markets
Dublin, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The "Food Allergy Market: Industry Size, Share, Competition, Trends, Growth Opportunities and Forecasts by Region - Insights and Outlook by Product, 2024 to...
Allergy Immunotherapy Soars: Anticipating a $2.69 Billion Market by 2028 with an Impressive CAGR of 8.12%
February 05, 2024 04:41 ET
|
Research and Markets
Dublin, Feb. 05, 2024 (GLOBE NEWSWIRE) -- The "Global Allergy Immunotherapy Market (2023-2028) by Type, Application and Distribution Channel, and Geography, Competitive Analysis, Impact of Covid-19,...
House Dust Mite Allergy Global Market Report 2024: Market will Grow from $1.9 Billion in 2023 to $3.69 Billion in 2028 - Long-term Forecast to 2033
January 24, 2024 07:35 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "House Dust Mite Allergy Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The house dust mite allergy market size...
Global Allergy Vaccine Market Report 2023: A $1.33 Billion Market in 2022 - Industry Size, Share, Trends, Opportunities, and Forecasts, 2018-2028F
January 24, 2024 05:03 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Allergy Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ResearchAndMarkets.com's...
Global Peanut Allergy Treatment Market Report 2024: Analysis by Drug Class, Antihistamines, Epinephrine - Forecasts to 2030
January 05, 2024 09:03 ET
|
Research and Markets
Dublin, Jan. 05, 2024 (GLOBE NEWSWIRE) -- The "Global Peanut Allergy Treatment Market Size, Share & Trends Analysis Report by Drug Class (Antihistamines, Epinephrine), Route Of Administration,...
Intrommune Therapeutics Presents Positive Results of Phase 1 OMEGA Study Investigating the Safety of INT301 Toothpaste for the Treatment of Peanut Allergy
November 09, 2023 11:01 ET
|
Intrommune Therapeutics
Intrommune Therapeutics Presents Positive Results of Phase 1 OMEGA Study Investigating the Safety of INT301 Toothpaste for the Treatment Peanut Allergy
Global Allergy Diagnostics Strategic Market Report 2023-2030 - Inhaled Allergens Segment to Witness Fastest Growth
October 12, 2023 06:18 ET
|
Research and Markets
Dublin, Oct. 12, 2023 (GLOBE NEWSWIRE) -- The "Allergy Diagnostics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Allergy Diagnostics Market...
In the Wake of Nestlé's Divestiture of Palforzia, New Market Report Sheds Light on the Global Allergy Immunotherapy Landscape for 2023
September 05, 2023 10:44 ET
|
Research and Markets
Dublin, Sept. 05, 2023 (GLOBE NEWSWIRE) -- A newly released research report on the Allergy Immunotherapy Global Market for 2023 forecasts a market growth from $2.34 billion in 2022 to $2.59 billion...
Peanut Allergy Treatment Industry Assessment 2023-2030: Surging Towards $1 Billion with Promising Pipeline Progress
August 29, 2023 05:08 ET
|
Research and Markets
Dublin, Aug. 29, 2023 (GLOBE NEWSWIRE) -- The "Peanut Allergy Treatment Market Size, Share & Trends Analysis Report By Drug Class (Antihistamines, Epinephrine), By Route Of Administration, By...
Intrommune Therapeutics Completes Last Patient Last Visit in the Phase 1 OMEGA Study for Peanut Allergy
July 25, 2023 09:35 ET
|
Intrommune Therapeutics
NEW YORK, July 25, 2023 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, Inc., a clinical stage biotechnology company developing a patient-friendly treatment platform for peanut and other food...